Highly expressible genes

Details for Australian Patent Application No. 2002211524 (hide)

Owner The Trustees of the University of Pennsylvania

Inventors Weiner, David B.; Yang, Joo-Sung

Agent FB Rice

Pub. Number AU-B-2002211524

PCT Pub. Number WO02/29088

Priority 60/237,885 04.10.00 US

Filing date 4 October 2001

Wipo publication date 15 April 2002

Acceptance publication date 22 March 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

Event Publications

22 March 2007 Application Accepted

  Published as AU-B-2002211524

19 July 2007 Standard Patent Sealed

29 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211525

2002211523